Pharmaceutical Technology: News, Analysis & Industry Insights

News

FDA approves Teva’s monthly injection of olanzapine for schizophrenia

Teva said it is debuting the drug to overcome adherence issues with an oral counterpart and improve symptom outcomes.

Robert Barrie

News

FDA approves Asahi Kasei’s Hovilpri for refractory HSV

Salong Debbarma

News

Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO

Robert Barrie

News

Perceptive, Nucleus partner to support radiopharmaceutical development

News

Roche’s Tecentriq snags FDA label expansion in type of colon cancer

News

Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout

News

Biohaven partners with Ono in $100m IgG degrader deal

News

Bio-Techne opens GMP small molecule facility in Bristol, UK

Analysis

Features

Women’s health landscape shifting, but systemic hurdles remain

Annabel Kartal Allen

Analyst Comment

CPHI 2026: Finding the right CDMO partner in an age of consolidation

Dominic Tyer

Features

Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed

Manasi Vaidya

PremiumAnalyst Comment

Suspected plague outbreak in Russia: public health risk lower than Covid-19

GlobalData Healthcare

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

$17995.00

Parkinson's Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

$17995.00

Emerging Market Outsourcing Report - Q3 2026

$2950.00

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

$3495.00

Alzheimer’s Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

FDA approves Asahi Kasei’s Hovilpri for refractory HSV

Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO

Perceptive, Nucleus partner to support radiopharmaceutical development

Roche’s Tecentriq snags FDA label expansion in type of colon cancer

Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout

Biohaven partners with Ono in $100m IgG degrader deal

Bio-Techne opens GMP small molecule facility in Bristol, UK

Women’s health landscape shifting, but systemic hurdles remain

CPHI 2026: Finding the right CDMO partner in an age of consolidation

Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed

Suspected plague outbreak in Russia: public health risk lower than Covid-19

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

Parkinson's Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Emerging Market Outsourcing Report - Q3 2026

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

Alzheimer’s Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

Parkinson's Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Emerging Market Outsourcing Report - Q3 2026

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

Alzheimer’s Disease: Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing